Global Oncology Molecular Diagnostics Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	174 Pages	TechNavio	July, 2023	INF18150529

Best Price Guarantee
Price	from $2,500
Length	174 Pages
Publisher	TechNavio
Published Date	July, 2023
SKU	INF18150529

Global Oncology Molecular Diagnostics Market 2023-2027

The oncology molecular diagnostics market is forecasted to grow by USD 2980.87 mn during 2022-2027, accelerating at a CAGR of 11.82% during the forecast period. The report on the oncology molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer worldwide, growing geriatric population, and increase in adoption of microarrays in genomics and proteomics.

Technavio's oncology molecular diagnostics market is segmented as below:

By Product

Reagents and kits
Instruments

By Type

Breast cancer
Colorectal cancer
Prostate cancer
Liver cancer and others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the integration of next-generation sequencing in oncology molecular diagnostics as one of the prime reasons driving the oncology molecular diagnostics market growth during the next few years. Also, adoption of various collaboration strategies and increasing focus on emerging countries for cancer diagnosis and treatment will lead to sizable demand in the market.

The report on the oncology molecular diagnostics market covers the following areas:

Oncology molecular diagnostics market sizing
Oncology molecular diagnostics market forecast
Oncology molecular diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology molecular diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., MDXHEALTH SA, Myriad Genetics Inc., QIAGEN NV, QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., TBG Diagnostics Ltd., Thermo Fisher Scientific Inc., and Veracyte Inc.. Also, the oncology molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Product; Exhibit 06: Executive Summary - Chart on Market Segmentation by Type; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global oncology molecular diagnostics market 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on global oncology molecular diagnostics market 2017 - 2021 ($ million); 4.2 Product Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million); 4.3 Type Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product: 6.1 Market segments; Exhibit 30: Chart on Product - Market share 2022-2027 (%); Exhibit 31: Data Table on Product - Market share 2022-2027 (%); 6.2 Comparison by Product; Exhibit 32: Chart on Comparison by Product; Exhibit 33: Data Table on Comparison by Product; 6.3 Reagents and kits - Market size and forecast 2022-2027; Exhibit 34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million); Exhibit 35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million); Exhibit 36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%); 6.4 Instruments - Market size and forecast 2022-2027; Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million); Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million); Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%); 6.5 Market opportunity by Product; Exhibit 42: Market opportunity by Product ($ million); Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Exhibit 44: Chart on Type - Market share 2022-2027 (%); Exhibit 45: Data Table on Type - Market share 2022-2027 (%); 7.2 Comparison by Type; Exhibit 46: Chart on Comparison by Type; Exhibit 47: Data Table on Comparison by Type; 7.3 Breast cancer - Market size and forecast 2022-2027; Exhibit 48: Chart on Breast cancer - Market size and forecast 2022-2027 ($ million); Exhibit 49: Data Table on Breast cancer - Market size and forecast 2022-2027 ($ million); Exhibit 50: Chart on Breast cancer - Year-over-year growth 2022-2027 (%); Exhibit 51: Data Table on Breast cancer - Year-over-year growth 2022-2027 (%); 7.4 Colorectal cancer - Market size and forecast 2022-2027; Exhibit 52: Chart on Colorectal cancer - Market size and forecast 2022-2027 ($ million); Exhibit 53: Data Table on Colorectal cancer - Market size and forecast 2022-2027 ($ million); Exhibit 54: Chart on Colorectal cancer - Year-over-year growth 2022-2027 (%); Exhibit 55: Data Table on Colorectal cancer - Year-over-year growth 2022-2027 (%); 7.5 Prostate cancer - Market size and forecast 2022-2027; Exhibit 56: Chart on Prostate cancer - Market size and forecast 2022-2027 ($ million); Exhibit 57: Data Table on Prostate cancer - Market size and forecast 2022-2027 ($ million); Exhibit 58: Chart on Prostate cancer - Year-over-year growth 2022-2027 (%); Exhibit 59: Data Table on Prostate cancer - Year-over-year growth 2022-2027 (%); 7.6 Liver cancer and others - Market size and forecast 2022-2027; Exhibit 60: Chart on Liver cancer and others - Market size and forecast 2022-2027 ($ million); Exhibit 61: Data Table on Liver cancer and others - Market size and forecast 2022-2027 ($ million); Exhibit 62: Chart on Liver cancer and others - Year-over-year growth 2022-2027 (%); Exhibit 63: Data Table on Liver cancer and others - Year-over-year growth 2022-2027 (%); 7.7 Market opportunity by Type; Exhibit 64: Market opportunity by Type ($ million); Exhibit 65: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2022-2027; Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.4 Europe - Market size and forecast 2022-2027; Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.5 Asia - Market size and forecast 2022-2027; Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%); 9.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 9.7 US - Market size and forecast 2022-2027; Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%); 9.8 China - Market size and forecast 2022-2027; Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%); 9.9 Germany - Market size and forecast 2022-2027; Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.10 Japan - Market size and forecast 2022-2027; Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million); Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million); Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%); 9.11 France - Market size and forecast 2022-2027; Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million); Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million); Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%); Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ million); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 115: Abbott Laboratories - Overview; Exhibit 116: Abbott Laboratories - Business segments; Exhibit 117: Abbott Laboratories - Key news; Exhibit 118: Abbott Laboratories - Key offerings; Exhibit 119: Abbott Laboratories - Segment focus; 12.4 Agilent Technologies Inc.; Exhibit 120: Agilent Technologies Inc. - Overview; Exhibit 121: Agilent Technologies Inc. - Business segments; Exhibit 122: Agilent Technologies Inc. - Key offerings; Exhibit 123: Agilent Technologies Inc. - Segment focus; 12.5 bioMerieux SA; Exhibit 124: bioMerieux SA - Overview; Exhibit 125: bioMerieux SA - Product / Service; Exhibit 126: bioMerieux SA - Key offerings; 12.6 Danaher Corp.; Exhibit 127: Danaher Corp. - Overview; Exhibit 128: Danaher Corp. - Business segments; Exhibit 129: Danaher Corp. - Key news; Exhibit 130: Danaher Corp. - Key offerings; Exhibit 131: Danaher Corp. - Segment focus; 12.7 F. Hoffmann La Roche Ltd.; Exhibit 132: F. Hoffmann La Roche Ltd. - Overview; Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 134: F. Hoffmann La Roche Ltd. - Key news; Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus; 12.8 Hologic Inc.; Exhibit 137: Hologic Inc. - Overview; Exhibit 138: Hologic Inc. - Business segments; Exhibit 139: Hologic Inc. - Key news; Exhibit 140: Hologic Inc. - Key offerings; Exhibit 141: Hologic Inc. - Segment focus; 12.9 HTG Molecular Diagnostics Inc.; Exhibit 142: HTG Molecular Diagnostics Inc. - Overview; Exhibit 143: HTG Molecular Diagnostics Inc. - Product / Service; Exhibit 144: HTG Molecular Diagnostics Inc. - Key offerings; 12.10 Illumina Inc.; Exhibit 145: Illumina Inc. - Overview; Exhibit 146: Illumina Inc. - Business segments; Exhibit 147: Illumina Inc. - Key news; Exhibit 148: Illumina Inc. - Key offerings; Exhibit 149: Illumina Inc. - Segment focus; 12.11 Myriad Genetics Inc.; Exhibit 150: Myriad Genetics Inc. - Overview; Exhibit 151: Myriad Genetics Inc. - Product / Service; Exhibit 152: Myriad Genetics Inc. - Key offerings; 12.12 QIAGEN NV; Exhibit 153: QIAGEN NV - Overview; Exhibit 154: QIAGEN NV - Product / Service; Exhibit 155: QIAGEN NV - Key news; Exhibit 156: QIAGEN NV - Key offerings; 12.13 Siemens Healthineers AG; Exhibit 157: Siemens Healthineers AG - Overview; Exhibit 158: Siemens Healthineers AG - Business segments; Exhibit 159: Siemens Healthineers AG - Key news; Exhibit 160: Siemens Healthineers AG - Key offerings; Exhibit 161: Siemens Healthineers AG - Segment focus; 12.14 Sysmex Corp.; Exhibit 162: Sysmex Corp. - Overview; Exhibit 163: Sysmex Corp. - Business segments; Exhibit 164: Sysmex Corp. - Key offerings; Exhibit 165: Sysmex Corp. - Segment focus; 12.15 TBG Diagnostics Ltd.; Exhibit 166: TBG Diagnostics Ltd. - Overview; Exhibit 167: TBG Diagnostics Ltd. - Product / Service; Exhibit 168: TBG Diagnostics Ltd. - Key offerings; 12.16 Thermo Fisher Scientific Inc.; Exhibit 169: Thermo Fisher Scientific Inc. - Overview; Exhibit 170: Thermo Fisher Scientific Inc. - Business segments; Exhibit 171: Thermo Fisher Scientific Inc. - Key news; Exhibit 172: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 173: Thermo Fisher Scientific Inc. - Segment focus; 12.17 Veracyte Inc.; Exhibit 174: Veracyte Inc. - Overview; Exhibit 175: Veracyte Inc. - Product / Service; Exhibit 176: Veracyte Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 177: Inclusions checklist; Exhibit 178: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 179: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 180: Research methodology; Exhibit 181: Validation techniques employed for market sizing; Exhibit 182: Information sources; 13.5 List of abbreviations; Exhibit 183: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size - Data Table on global oncology molecular diagnostics market 2017 - 2021 ($ million); Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on Product - Market share 2022-2027 (%); Exhibits31: Data Table on Product - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by Product; Exhibits33: Data Table on Comparison by Product; Exhibits34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million); Exhibits35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million); Exhibits36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Instruments - Market size and forecast 2022-2027 ($ million); Exhibits39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million); Exhibits40: Chart on Instruments - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Instruments - Year-over-year growth 2022-2027 (%); Exhibits42: Market opportunity by Product ($ million); Exhibits43: Data Table on Market opportunity by Product ($ million); Exhibits44: Chart on Type - Market share 2022-2027 (%); Exhibits45: Data Table on Type - Market share 2022-2027 (%); Exhibits46: Chart on Comparison by Type; Exhibits47: Data Table on Comparison by Type; Exhibits48: Chart on Breast cancer - Market size and forecast 2022-2027 ($ million); Exhibits49: Data Table on Breast cancer - Market size and forecast 2022-2027 ($ million); Exhibits50: Chart on Breast cancer - Year-over-year growth 2022-2027 (%); Exhibits51: Data Table on Breast cancer - Year-over-year growth 2022-2027 (%); Exhibits52: Chart on Colorectal cancer - Market size and forecast 2022-2027 ($ million); Exhibits53: Data Table on Colorectal cancer - Market size and forecast 2022-2027 ($ million); Exhibits54: Chart on Colorectal cancer - Year-over-year growth 2022-2027 (%); Exhibits55: Data Table on Colorectal cancer - Year-over-year growth 2022-2027 (%); Exhibits56: Chart on Prostate cancer - Market size and forecast 2022-2027 ($ million); Exhibits57: Data Table on Prostate cancer - Market size and forecast 2022-2027 ($ million); Exhibits58: Chart on Prostate cancer - Year-over-year growth 2022-2027 (%); Exhibits59: Data Table on Prostate cancer - Year-over-year growth 2022-2027 (%); Exhibits60: Chart on Liver cancer and others - Market size and forecast 2022-2027 ($ million); Exhibits61: Data Table on Liver cancer and others - Market size and forecast 2022-2027 ($ million); Exhibits62: Chart on Liver cancer and others - Year-over-year growth 2022-2027 (%); Exhibits63: Data Table on Liver cancer and others - Year-over-year growth 2022-2027 (%); Exhibits64: Market opportunity by Type ($ million); Exhibits65: Data Table on Market opportunity by Type ($ million); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million); Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million); Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%); Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million); Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million); Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%); Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%); Exhibits107: Market opportunity By Geographical Landscape ($ million); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits109: Impact of drivers and challenges in 2022 and 2027; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: Abbott Laboratories - Overview; Exhibits116: Abbott Laboratories - Business segments; Exhibits117: Abbott Laboratories - Key news; Exhibits118: Abbott Laboratories - Key offerings; Exhibits119: Abbott Laboratories - Segment focus; Exhibits120: Agilent Technologies Inc. - Overview; Exhibits121: Agilent Technologies Inc. - Business segments; Exhibits122: Agilent Technologies Inc. - Key offerings; Exhibits123: Agilent Technologies Inc. - Segment focus; Exhibits124: bioMerieux SA - Overview; Exhibits125: bioMerieux SA - Product / Service; Exhibits126: bioMerieux SA - Key offerings; Exhibits127: Danaher Corp. - Overview; Exhibits128: Danaher Corp. - Business segments; Exhibits129: Danaher Corp. - Key news; Exhibits130: Danaher Corp. - Key offerings; Exhibits131: Danaher Corp. - Segment focus; Exhibits132: F. Hoffmann La Roche Ltd. - Overview; Exhibits133: F. Hoffmann La Roche Ltd. - Business segments; Exhibits134: F. Hoffmann La Roche Ltd. - Key news; Exhibits135: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits136: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits137: Hologic Inc. - Overview; Exhibits138: Hologic Inc. - Business segments; Exhibits139: Hologic Inc. - Key news; Exhibits140: Hologic Inc. - Key offerings; Exhibits141: Hologic Inc. - Segment focus; Exhibits142: HTG Molecular Diagnostics Inc. - Overview; Exhibits143: HTG Molecular Diagnostics Inc. - Product / Service; Exhibits144: HTG Molecular Diagnostics Inc. - Key offerings; Exhibits145: Illumina Inc. - Overview; Exhibits146: Illumina Inc. - Business segments; Exhibits147: Illumina Inc. - Key news; Exhibits148: Illumina Inc. - Key offerings; Exhibits149: Illumina Inc. - Segment focus; Exhibits150: Myriad Genetics Inc. - Overview; Exhibits151: Myriad Genetics Inc. - Product / Service; Exhibits152: Myriad Genetics Inc. - Key offerings; Exhibits153: QIAGEN NV - Overview; Exhibits154: QIAGEN NV - Product / Service; Exhibits155: QIAGEN NV - Key news; Exhibits156: QIAGEN NV - Key offerings; Exhibits157: Siemens Healthineers AG - Overview; Exhibits158: Siemens Healthineers AG - Business segments; Exhibits159: Siemens Healthineers AG - Key news; Exhibits160: Siemens Healthineers AG - Key offerings; Exhibits161: Siemens Healthineers AG - Segment focus; Exhibits162: Sysmex Corp. - Overview; Exhibits163: Sysmex Corp. - Business segments; Exhibits164: Sysmex Corp. - Key offerings; Exhibits165: Sysmex Corp. - Segment focus; Exhibits166: TBG Diagnostics Ltd. - Overview; Exhibits167: TBG Diagnostics Ltd. - Product / Service; Exhibits168: TBG Diagnostics Ltd. - Key offerings; Exhibits169: Thermo Fisher Scientific Inc. - Overview; Exhibits170: Thermo Fisher Scientific Inc. - Business segments; Exhibits171: Thermo Fisher Scientific Inc. - Key news; Exhibits172: Thermo Fisher Scientific Inc. - Key offerings; Exhibits173: Thermo Fisher Scientific Inc. - Segment focus; Exhibits174: Veracyte Inc. - Overview; Exhibits175: Veracyte Inc. - Product / Service; Exhibits176: Veracyte Inc. - Key offerings; Exhibits177: Inclusions checklist; Exhibits178: Exclusions checklist; Exhibits179: Currency conversion rates for US$; Exhibits180: Research methodology; Exhibits181: Validation techniques employed for market sizing; Exhibits182: Information sources; Exhibits183: List of abbreviations